Patents by Inventor Ozkan SARI

Ozkan SARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Elimination of hepatitis b virus with antiviral agents
    Patent number: 11629125
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: April 18, 2023
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS
    Publication number: 20210114981
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Application
    Filed: August 20, 2020
    Publication date: April 22, 2021
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • Elimination of hepatitis B virus with antiviral agents
    Patent number: 10752584
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: August 25, 2020
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Sebastien Boucle, Franck Amblard, Ozkan Sari, Leda Bassit
  • ELIMINATION OF HEPATITIS B VIRUS WITH ANTIVIRAL AGENTS
    Publication number: 20190241514
    Abstract: The present invention is directed to compounds, compositions and methods for preventing, treating or curing Hepatitis B (HBV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment, prevention or eradication of HBV infection.
    Type: Application
    Filed: March 9, 2017
    Publication date: August 8, 2019
    Applicant: EMORY UNIVERSITY
    Inventors: Raymond F. SCHINAZI, Sebastien BOUCLE, Franck AMBLARD, Ozkan SARI, Leda BASSIT
  • PROCESSES FOR PREPARING 2-DIHALO RIBOLACTONES
    Publication number: 20190077797
    Abstract: Methods for forming 2-bromo, 2-fluoro ribofuranose intermediates and 2-chloro, 2-fluoro ribofuranose intermediates for use in preparing antiviral nucleosides are disclosed. Methods for forming nucleosides, and nucleoside prodrugs, using the intermediates, are also disclosed. The methods all produce intermediates, and the resulting nucleosides and prodrugs thereof, wherein the chirality of the carbon at the 2-position is controlled. In some embodiments, the chemistry involves using chiral auxiliaries, such as (R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde, and in other embodiments, the chemistry involves using chiral starting materials, such as D-xylose.
    Type: Application
    Filed: October 31, 2016
    Publication date: March 14, 2019
    Inventors: Ozkan SARI, Coralie DE SCHUTTER, Jong-Hyun CHO, Longhu ZHOU, Hongwang ZANG, Franck AMBLARD, Steven J. COATS, Raymond F. SCHINAZI